Tag: Nephrology
-

Fish Oil in Dialysis: PISCES Trial Reduces Heart Risks
Overview: A potential breakthrough for dialysis patients A new study presented at Kidney Week 2025 and published simultaneously in The New England Journal of Medicine spotlighted a daily fish oil supplement as a potential way to reduce serious heart risks in people undergoing dialysis. The trial, known as PISCES, followed 1,228 participants across 26 sites…
-

Daily Fish Oil Slashes Heart Risks in Dialysis Patients, PISCES Trial Finds
New evidence links fish oil to reduced heart risk for dialysis patients A large, multinational study has found that daily fish oil supplementation may significantly cut the risk of serious heart events among people undergoing dialysis. The PISCES trial followed 1,228 participants across 26 sites in Australia and Canada, tracking outcomes over a period designed…
-

Fish Oil Reduces Heart Risk in Dialysis Patients: PISCES Trial
What the PISCES Trial Found A large, multi-site study known as the PISCES trial examined whether daily fish oil supplements could lower cardiovascular risks among people receiving dialysis. Encompassing 1,228 participants at 26 sites across Australia and Canada, the trial tracked health outcomes over a defined period and evaluated whether omega-3 fatty acids could translate…
-

Sparsentan Delivers Positive Phase 3 Results in Japanese IgA Nephropathy
Overview: sparsentan earns positive topline data in Japanese IgA nephropathy Renalys Pharmaceutical Co. announced encouraging topline results from a Phase 3 study evaluating sparsentan, a dual-acting agent, in Japanese patients with IgA nephropathy (IgAN). The trial focused on the safety and efficacy of sparsentan in a specific, well-defined cohort (N=35) and sought to determine whether…
-

A New Drug Shields Mitochondria to Prevent Kidney Injury in Mice
Researchers unveil a mitochondria-focused approach to preventing kidney injury Acute kidney injury (AKI) remains a serious and sometimes fatal complication in hospitalized patients, especially those facing sepsis, major surgery, or intensive care treatments. A new preclinical study from researchers at the University of Utah Health suggests a novel drug can protect kidney cells by preserving…
-

New Drug Shields Mitochondria and Prevents Kidney Injury in Mice
Scientists unveil a breakthrough drug that protects mitochondria and guards against acute kidney injury Acute kidney injury (AKI) is a serious and sometimes fatal condition triggered by a range of stressors, from sepsis to surgical shock. It can rapidly impair short-term kidney function and increase the long-term risk of chronic kidney disease. In a new…
-

New drug protects mitochondria and prevents kidney injury in mice
Overview: A breakthrough in protecting the kidneys Acute kidney injury (AKI) can be a serious, life-threatening condition that disrupts short-term kidney function and raises the risk of long-term chronic kidney disease. Researchers are continually seeking strategies to prevent AKI and minimize kidney damage when stressors such as sepsis, toxins, or surgical procedures trigger the injury.…



